{
    "clinical_study": {
        "@rank": "102390", 
        "arm_group": {
            "arm_group_label": "SYR-472 100mg", 
            "arm_group_type": "Experimental", 
            "description": "SYR-472 100mg"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the efficacy and safety of treatment with SYR-472 in diabetic patients."
        }, 
        "brief_title": "SYR-472 Open-label Study", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -1. The participant is judged to be capable of understanding and complying with protocol\n        requirements by the investigator or subinvestigator.\n\n        2. The participant can sign and date a written, informed consent form prior to the\n        initiation of any study procedures.\n\n        Exclusion Criteria:\n\n        -1. The participant has concurrent serious cardiac disease, serious cerebrovascular\n        disorder, or serious pancreatic or hematological disease\n\n        . 2. The participant is assessed to be ineligible for the study by the investigator or\n        subinvestigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01751360", 
            "org_study_id": "SYR-472/OCT-002", 
            "secondary_id": [
                "U1111-1137-2768", 
                "JapicCTI-122024"
            ]
        }, 
        "intervention": {
            "arm_group_label": "SYR-472 100mg", 
            "intervention_name": "SYR-472", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suita-shi", 
                    "country": "Japan", 
                    "state": "Osaka"
                }
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "overall_official": {
            "affiliation": "Takeda", 
            "last_name": "General Manager", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Blood Glucose", 
            "measure": "Blood Glucose", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01751360"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Takeda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}